Clinical Trials Directory

Trials / Completed

CompletedNCT05459064

Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction

Status
Completed
Phase
Study type
Observational
Enrollment
144 (actual)
Sponsor
Establishment Labs · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Motiva Flora® TE are intended for temporary subcutaneous or submuscular implantation to develop surgical flaps and additional tissue coverage and are not intended for use beyond six (6) months. All Motiva Flora® TE's require periodic, incremental inflation with sterile saline for injection until the desired tissue amount is developed. After the desired volume, the expander is surgically removed and replaced with a long-term breast implant in the same space as the tissue expander. The study collects retrospective data on the use of the Motiva Flora TE, from patients who had a tissue expander-based-breast reconstruction using the Motiva Flora® TE since market introduction in May 2020.

Conditions

Interventions

TypeNameDescription
DEVICEMotiva Flora TEThis is a retrospective, observational study - collecting data on patients who have gone through the staged procedure with the Motiva Flora Tissue Expander / Long-term breast implant.

Timeline

Start date
2022-09-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2022-07-14
Last updated
2024-08-27

Locations

2 sites across 2 countries: Belgium, Spain

Source: ClinicalTrials.gov record NCT05459064. Inclusion in this directory is not an endorsement.